- Home
- ALVO
ALVO
Alvotech
as 12-26-2024 10:30am EST
Alvotech is an integrated biopharmaceutical company committed to developing and manufacturing high-quality biosimilar medicines for patients globally. its purpose is to improve the health and quality of life of patients around the world by improving access to proven treatments for various diseases.
| Founded: | 2013 | Country: | Luxembourg |
| Employees: | N/A | City: | N/A |
| Market Cap: | 3.4B | IPO Year: | N/A |
| Target Price: | $18.00 | AVG Volume (30 days): | 145.5K |
| Analyst Decision: | Buy | Number of Analysts: | 1 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.74 | EPS Growth: | N/A |
| 52 Week Low/High: | $9.15 - $18.00 | Next Earning Date: | 11-13-2024 |
| Revenue: | $393,919,000 | Revenue Growth: | 517.92% |
| Revenue Growth (this year): | 398.12% | Revenue Growth (next year): | 44.73% |
Latest Alvotech News
ALVO Breaking Stock News: Dive into ALVO Ticker-Specific Updates for Smart Investing
GlobeNewswire
3 days ago
Alvotech Added to Nasdaq Biotech Index Effective Monday December 23, 2024
Simply Wall St.
10 days ago
Exploring Three High Growth Tech Stocks in the United States
Simply Wall St.
a month ago
Alvotech Third Quarter 2024 Earnings: US$0.041 loss per share (vs US$0.81 loss in 3Q 2023)
GuruFocus.com
a month ago
Alvotech (ALVO) Q3 2024 Earnings Call Highlights: Record Revenue Growth and Strategic Advancements
GlobeNewswire
a month ago
Alvotech Reports Financial Results for the First Nine Months of 2024
GlobeNewswire
2 months ago
Alvotech Attending Citi's Global Healthcare Conference on December 4, 2024, and Evercore’s HealthCONx Conference on December 5, 2024
GlobeNewswire
2 months ago
European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)
GlobeNewswire
2 months ago
Alvotech to Report Financial Results for the First Nine Months of 2024 on November 13, 2024, and Host Conference Call on November 14, 2024, at 8:00 am ET
Compare ALVO vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ALVO Alvotech - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.